ArticleAnnals of translational medicine2021

Dual inhibition of RNAi therapeutic miR-26a-5p targeting cMet and immunotherapy against EGFR in endometrial cancer treatment.

Yun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.